NO20084253L - Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon - Google Patents

Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon

Info

Publication number
NO20084253L
NO20084253L NO20084253A NO20084253A NO20084253L NO 20084253 L NO20084253 L NO 20084253L NO 20084253 A NO20084253 A NO 20084253A NO 20084253 A NO20084253 A NO 20084253A NO 20084253 L NO20084253 L NO 20084253L
Authority
NO
Norway
Prior art keywords
memory function
tetrahydroisoquinoline derivatives
improve memory
tetrahydroisoquinoline
derivatives
Prior art date
Application number
NO20084253A
Other languages
English (en)
Inventor
Francois Jenck
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of NO20084253L publication Critical patent/NO20084253L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen vedrører anvendelsen av tetrahydroisokinolinderivater for fremstilling av et medikament for å forbedre, opprettholde de og/eller gjenopprette alle stadier og/eller typer av kort-, mellomlang- og/eller langtidshukommelse.
NO20084253A 2006-03-15 2008-10-10 Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon NO20084253L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006050812 2006-03-15
PCT/IB2007/050868 WO2007105177A1 (en) 2006-03-15 2007-03-14 Tetrahydroisoquinoline derivatives to enhance memory function

Publications (1)

Publication Number Publication Date
NO20084253L true NO20084253L (no) 2008-10-10

Family

ID=38181192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084253A NO20084253L (no) 2006-03-15 2008-10-10 Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon

Country Status (16)

Country Link
US (1) US20090082394A1 (no)
EP (1) EP1998774A1 (no)
JP (3) JP4582722B2 (no)
KR (1) KR101065239B1 (no)
CN (1) CN101400348A (no)
AU (1) AU2007226203A1 (no)
BR (1) BRPI0708913A2 (no)
CA (1) CA2644010A1 (no)
CR (1) CR10260A (no)
EA (1) EA015256B1 (no)
IL (1) IL194044A0 (no)
MA (1) MA30327B1 (no)
MX (1) MX2008011647A (no)
NO (1) NO20084253L (no)
UA (1) UA93903C2 (no)
WO (1) WO2007105177A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4094050B2 (ja) 2004-03-01 2008-06-04 アクテリオン ファーマシューティカルズ リミテッド 置換１，２，３，４−テトラヒドロイソキノリン誘導体
EP1998774A1 (en) * 2006-03-15 2008-12-10 Actelion Pharmaceuticals Ltd. Tetrahydroisoquinoline derivatives to enhance memory function
ATE496051T1 (de) * 2006-04-26 2011-02-15 Actelion Pharmaceuticals Ltd Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
ES2380391T3 (es) 2006-12-22 2012-05-11 Actelion Pharmaceuticals Ltd. Derivados de 5,6,7,8-tetrahidro-imidazo[1,5-a]pirazina
ES2365444T3 (es) * 2007-04-04 2011-10-05 F. Hoffmann-La Roche Ag Heterociclos como antagonistas de orexina.
PE20091010A1 (es) 2007-10-10 2009-08-08 Actelion Pharmaceuticals Ltd Derivados de tetrahidroquinolina
WO2009079637A1 (en) 2007-12-18 2009-06-25 Concert Pharmaceuticals, Inc. Tetrahydroisoquinoline derivatives
EP2227455B1 (en) * 2007-12-28 2011-10-12 Actelion Pharmaceuticals Ltd. Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
US20110105514A1 (en) 2008-06-25 2011-05-05 Hamed Aissaoui 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
WO2010095106A1 (en) 2009-02-20 2010-08-26 Actelion Pharmaceuticals Ltd Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride
TW201209037A (en) 2010-08-24 2012-03-01 Actelion Pharmaceuticals Ltd Proline sulfonamide derivatives as orexin receptor antagonists
SI2626350T1 (sl) 2010-09-22 2015-09-30 Eisai R&D Management Co., Ltd. Spojina ciklopropana
WO2012063207A1 (en) 2010-11-10 2012-05-18 Actelion Pharmaceuticals Ltd Lactam derivatives useful as orexin receptor antagonists
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
WO2012110986A1 (en) 2011-02-18 2012-08-23 Actelion Pharmaceuticals Ltd Novel pyrazole and imidazole derivatives useful as orexin antagonists
WO2012114252A1 (en) 2011-02-21 2012-08-30 Actelion Pharmaceuticals Ltd Novel indole and pyrrolopyridine amides
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
DK2776430T3 (en) 2011-11-08 2016-05-09 Actelion Pharmaceuticals Ltd 2- (1,2,3-triazol-2-yl) benzamide and 3- (1,2,3-triazol-2-yl) PICOLINAMIDDERIVATER AS orexin receptor antagonists
TWI570120B (zh) 2012-06-04 2017-02-11 艾克泰聯製藥有限公司 苯并咪唑脯胺酸衍生物
AU2013328301A1 (en) 2012-10-10 2015-05-28 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero-)aryl]-[2-(meta bi (hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
CN105051040A (zh) 2013-03-12 2015-11-11 埃科特莱茵药品有限公司 作为食欲素受体拮抗剂的氮杂环丁烷酰胺衍生物
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
JP6496733B2 (ja) 2013-12-03 2019-04-03 イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ （ｓ）−（２−（６−クロロ−７−メチル−１ｈ−ベンゾ［ｄ］イミダゾール−２−イル）−２−メチルピロリジン−１−イル）（５−メトキシ−２−（２ｈ−１，２，３−トリアゾール−２−イル）フェニル）メタノンの結晶形及びオレキシン受容体アンタゴニストとしてのその使用
KR102330133B1 (ko) 2013-12-04 2021-11-23 이도르시아 파마슈티컬스 리미티드 벤즈이미다졸-프롤린 유도체의 용도
SG10202007759RA (en) 2014-10-23 2020-09-29 Eisai R&D Man Co Ltd Compositions and methods for treating insomnia
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 (en) 2018-07-06 2020-01-09 Idorsia Pharmaceuticals Ltd 7-trifluoromethyl-[1,4]diazepan derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
TW202400149A (zh) 2022-05-13 2024-01-01 瑞士商愛杜西亞製藥有限公司 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703050B1 (fr) * 1993-03-24 1995-04-28 Adir Nouveaux dérivés bicycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
GB9319732D0 (en) * 1993-09-24 1993-11-10 Ucb Sa Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
JP3942207B2 (ja) * 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
AU6011301A (en) * 2000-03-14 2001-09-24 Actelion Pharmaceuticals Ltd 1,2,3,4-tetrahydroisoquinoline derivatives
CA2408343A1 (en) * 2000-05-11 2002-11-07 Banyu Pharmaceutical Co., Ltd. N-acyltetrahydroisoquinoline derivatives
WO2002051232A2 (en) * 2000-12-27 2002-07-04 Actelion Pharmaceuticals Ltd. Novel benzazepines and related heterocyclic derivatives
HRP20040952A2 (en) * 2002-04-26 2005-06-30 F. Hoffmann - La Roche Ag Isoquinoline derivatives
AU2004224156B2 (en) * 2003-03-26 2010-08-12 Actelion Pharmaceuticals Ltd. Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
JP4094050B2 (ja) 2004-03-01 2008-06-04 アクテリオン ファーマシューティカルズ リミテッド 置換１，２，３，４−テトラヒドロイソキノリン誘導体
FR2874011B1 (fr) * 2004-08-03 2007-06-15 Sanofi Synthelabo Derives de sulfonamides, leur preparation et leur application en therapeutique
EP1998774A1 (en) * 2006-03-15 2008-12-10 Actelion Pharmaceuticals Ltd. Tetrahydroisoquinoline derivatives to enhance memory function

Also Published As

Publication number Publication date
JP2010270127A (ja) 2010-12-02
US20090082394A1 (en) 2009-03-26
BRPI0708913A2 (pt) 2011-06-14
EA200870357A1 (ru) 2009-02-27
UA93903C2 (ru) 2011-03-25
JP2010248237A (ja) 2010-11-04
KR20080103597A (ko) 2008-11-27
JP2009530265A (ja) 2009-08-27
IL194044A0 (en) 2009-09-22
AU2007226203A1 (en) 2007-09-20
EA015256B1 (ru) 2011-06-30
CN101400348A (zh) 2009-04-01
MA30327B1 (fr) 2009-04-01
CR10260A (no) 2008-10-03
WO2007105177A1 (en) 2007-09-20
MX2008011647A (es) 2008-09-22
CA2644010A1 (en) 2007-09-20
JP4582722B2 (ja) 2010-11-17
KR101065239B1 (ko) 2011-09-16
EP1998774A1 (en) 2008-12-10

Similar Documents

Publication Publication Date Title
UA93903C2 (ru) Производные тетрагидроизохинолина для повышения функции памяти
NO20071095L (no) Hittil ukjente tiofenderivater
NO20082793L (no) Nye tiofenderivater
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
ATE424159T1 (de) Katheter
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
PT2049557E (pt) Derivados de 1-(d-glicopiranosil)-3-(4- ciclopropilfenilmetil)-4-halogeno-indol e a sua utiliza??o como inibidores de tgds
ATE447568T1 (de) Neue pyrinderivate
NO20090596L (no) Antivirale fosfinatforbindelser
WO2008070268A3 (en) Pharmaceutical compositions
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
NO20082298L (no) Kaliumkanalinhibitorer
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
AR054507A1 (es) Sistema transdermico de vareniclina
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
CL2010001421A1 (es) Uso de dronedarona en la preparacion de medicamentos utiles para la prevencion de fibrilacion o aleteo auricular persistentes.
NO20091386L (no) Fenyloksyanilinderivater
WO2007130902A3 (en) Therapeutic cyclopentane derivatives
CY1110787T1 (el) Νεα μορφινικα παραγωγα
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
NO20085267L (no) Derivater av 2-alkoksy -3,4,5-trihydroksy-alkyl amider, fremstilling og anvendelse derav, samt sammensetninger inneholdende samme
ATE526972T1 (de) Kaliumkanalhemmer
WO2007014671A3 (de) KOMBINATIONEN MIT IKK-ß INHIBITOREN
CN300800506S (zh) 药品包装盒(抗宫炎片40片otc)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application